Screener
Novavax NVAX Provision for excess and obsolete inventory
Provision for excess and obsolete inventory at other companies
Other financials
Where this comes from
Reported directly by Novavax in its filing.
Tagged under the XBRL concept nvax:ProvisionForExcessAndObsoleteInventory.
The source filing: Novavax’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:50 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001000694-26-000018
FAQ
- What is Novavax's provision for excess and obsolete inventory?
- Novavax (NVAX) reported provision for excess and obsolete inventory of $1.6M in Q2 2026.
- How has Novavax's provision for excess and obsolete inventory changed year-over-year?
- Novavax's provision for excess and obsolete inventory increased by 44.8% year-over-year, from $1.1M to $1.6M.
- What is the long-term trend for Novavax's provision for excess and obsolete inventory?
- Over 3 years (2022 to 2025), Novavax's provision for excess and obsolete inventory has grown at a -83.7% compound annual growth rate (CAGR), from $447.6M to $1.95M.
- What does provision for excess and obsolete inventory mean?
- Provision for excess and obsolete inventory as reported by Novavax Inc.
Ask your AI about Novavax's provision for excess and obsolete inventory.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude